Connect with us

Business

Pfizer plans to file for full FDA approval of Covid vaccine at the end of this month – CNBC

In its earnings report, Pfizer reported $3.5 billion in first-quarter sales of its Covid-19 vaccine.

Published

on

Article feature image
ADVERTISEMENT

Pfizer said Tuesday it plans to file for full U.S. approval of its Covid-19 vaccine with German drugmaker BioNTech at the end of this month. If the FDA signs off, the company will be able to market the shot directly to consumers.
In its earnings report, Pfizer said first-quarter sales of its Covid-19 vaccine was $3.5 billion. It reported earnings and revenue that beat Wall Street’s expectations.
Here’s how Pfizer did compared with what Wall Street expected, according to average estimates compiled…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Cyberattack forces major US fuel pipeline to shut down – CNN
Article feature image
IHOP responds to Adam Sandler with all-you-can-drink milkshakes – Fox News
Article feature image
How Many Bitcoin Wallets Hold More Than $1 Million? – Bitcoin Magazine